Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

50.73 -2.12 (-4.01%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

These S&P500 stocks are gapping in today's session ↗

April 24, 2026

Via Chartmill

3 Healthcare Stocks With the Most Durable Competitive Moats ↗

April 23, 2026

These companies offer a clear path to sustained earnings growth.

Via The Motley Fool

Topics Intellectual Property

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

April 21, 2026

Via ACCESS Newswire

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth ↗

April 21, 2026

It will be a turbulent ride, but patient investors might come out of it much richer.

Via The Motley Fool

Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting

April 21, 2026

Via ACCESS Newswire

Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

April 21, 2026

Via ACCESS Newswire

Moderna to Present at Upcoming Conferences in May 2026

April 21, 2026

Via ACCESS Newswire

What's Pushing Moderna Stock Higher Today? ↗

April 20, 2026

Moderna (NASDAQ:MRNA) shares are moving higher on Monday after the company won FDA Fast Track status for an oncology program.

Via Benzinga

Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting

April 17, 2026

Via ACCESS Newswire

Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026

April 15, 2026

Via ACCESS Newswire

April 14, 2026

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...

Via StockStory

A $2 Trillion IPO and the Space Economy ↗

April 10, 2026

We discuss the hottest IPO ever, SpaceX, and what the future of the space economy might look like.

Via The Motley Fool

Topics Economy Initial Public Offering

Meet the 2 Formerly Down-and-Out Stocks That Are Outperforming the S&P 500 This Year. Are They Still a Buy? ↗

April 09, 2026

These stocks have surged in the double-digits.

Via The Motley Fool

Topics Artificial Intelligence Stocks

3 Mid-Cap Stocks We’re Skeptical Of

April 09, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...

Via StockStory

Looks Like M&A Week in 3 Different Sectors ↗

April 08, 2026

Some large merger & acquisition deals that could shake up the consumer goods and the food distribution industry, plus deals in the healthcare industry.

Via The Motley Fool

You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. ↗

April 07, 2026

Could this player be heading into a new era of growth?

Via The Motley Fool

Topics Artificial Intelligence Economy Stocks

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

April 06, 2026

Via ACCESS Newswire

2 S&P 500 Stocks with Exciting Potential and 1 We Ignore

April 03, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ...

Via StockStory

Topics Stocks

Roivant and Immunovant Solidify Market Leadership as Brepocitinib and FcRn Programs Hit Critical Clinical Milestones

April 02, 2026

The biotechnology sector witnessed a seismic shift this week as Roivant Sciences (Nasdaq: ROIV) and its subsidiary Immunovant (Nasdaq: IMVT) reported a series of clinical and regulatory updates that...

Via MarketMinute

Topics Intellectual Property

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

April 02, 2026

What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and pa...

Via StockStory

Topics Government Stocks World Trade

Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability

March 31, 2026

As of March 31, 2026, Moderna Inc. (NASDAQ: MRNA) finds itself at a defining historical junction. After years of being defined by a single, world-altering product—its COVID-19 vaccine—the...

Via Finterra

Topics Initial Public Offering

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Economy Government Stocks

Stay informed with the top movers within the S&P500 index on Friday. ↗

March 27, 2026

Via Chartmill

These S&P500 stocks are gapping in today's session ↗

March 27, 2026

Via Chartmill

Corporate Fortress: S&P 500 Defies Gravity with Fifth Consecutive Quarter of Double-Digit Growth

March 27, 2026

The American corporate engine has proven far more durable than even the most optimistic analysts predicted just a year ago. As of March 27, 2026, final results for the fourth quarter of 2025 have...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

2 Healthcare Stocks That Could Soar Over the Next 5 Years ↗

March 26, 2026

They could make important breakthroughs in their target markets.

Via The Motley Fool

Global Growth Engine: Strong Trade and Production Fundamentals Propel U.S. Markets to Historic Highs

March 25, 2026

As of March 25, 2026, the global economic landscape has shifted from the volatility of previous years into a phase of "tenuous resilience." Fueled by a significant rebound in international trade and a...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Can the "AI Supercycle" Deliver a Fourth Consecutive Double-Digit Year for the S&P 500?

March 25, 2026

As of March 25, 2026, the S&P 500 stands at a critical crossroads. After a historic three-year run that saw the benchmark index post double-digit gains in 2023, 2024, and a robust 17.9% in 2025,...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Moderna Stock is Soaring. Is It Too Late to Buy? ↗

March 25, 2026

Moderna's full pipeline may fuel long-term growth.

Via The Motley Fool

Uncover the latest developments among S&P500 stocks in today's session. ↗

March 25, 2026

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.